Pharma Journalist 9027 posts 0 comments

Turn Therapeutics, a biotechnology company specializing in advanced wound care and infection control, announced the initiation of a two-part, four-arm, human safety and efficacy trial…
Read More...

Servier, a global and independent pharmaceutical Group, and MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced a research partnership to identify and develop small…
Read More...

Mitsubishi Tanabe Pharma America, Inc. and Aquestive Therapeutics, Inc. announced a licensing and supply deal for the U.S. rights to commercialize EXSERVAN (riluzole), an oral film…
Read More...

Akron Biotechnology, LLC (Akron Biotech), announced it has signed an exclusive global agreement to manufacture virally inactivated Human AB Serum for the cell therapy market using…
Read More...

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and…
Read More...

T-Cure Bioscience, Inc., a privately held clinical-stage immuno-oncology company developing the next generation of T cell receptor (TCR) therapies for patients with solid tumors, and…
Read More...

Gritstone Oncology, Inc. a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, announced that it is advancing…
Read More...

Cocrystal Pharma, Inc. a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses,…
Read More...

Thermo Fisher Scientific Inc. announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450…
Read More...

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company and Merus N.V. a clinical-stage oncology company developing multi-specific antibodies, today announced…
Read More...